Pear Therapeutics
Boston, US · Founded 2013 · Delaware corporation · 5 known investors
Pioneering the development of prescription digital therapeutics.
Healthtech
Founders & leadership
Pear Therapeutics was founded in 2013 by Corey McCann.
CM
Corey McCannFounder
AN
Antoun NabhanExecutive
CG
Christopher GuiffreExecutive
Board
AS
TP
ZL
Investors · 5
.png)
Reported raises · per SEC filings
Form D private placements$254.8M disclosed across 4 rounds · 2016–2020
▶$132MraisedMar 2021 · 22 investors · Other Health CareRule 506(b)
▶$132MraisedMar 2021 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew SchwabDirector
- Elena VibochDirector
- Nancy SchlichtingDirector
- Christopher GuiffreExecutive Officer
- Julia StrandbergExecutive Officer
- Yuri MaricichExecutive Officer
- Ronan O'BrienExecutive Officer
- Corey McCannExecutive Officer, Director
- Zack LynchDirector
- Timothy PetersenDirector
- Offering amount
- $132M
- Amount sold
- $132M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$64.3MraisedJan 2019 · 21 investors · Other Health CareRule 506(b)
▶$64.3MraisedJan 2019 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Timothy PetersenDirector
- Andrew SchwabDirector
- Jeremy GilbertExecutive Officer
- Alex WaldronExecutive Officer
- Hongjie HuDirector
- Corey McCannExecutive Officer, Director
- Zack LynchDirector
- Christopher GuiffreExecutive Officer
- Yuri MaricichExecutive Officer
- Offering amount
- $65M
- Amount sold
- $64.3M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$46MraisedJan 2018 · 14 investors · Other Health CareRule 506(b)
▶$46MraisedJan 2018 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Antoun NabhanExecutive Officer
- Corey McCannExecutive Officer, Director
- Andrew SchwabDirector
- Timothy PetersenDirector
- Christopher GuiffreExecutive Officer
- Zack LynchDirector
- Offering amount
- $51M
- Amount sold
- $46M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$12.4MraisedFeb 2016 · 13 investors · BiotechnologyRule 506(b)
▶$12.4MraisedFeb 2016 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew J. SchwabDirector
- Tim PetersenDirector
- Zack LynchDirector
- Corey McCannExecutive Officer, Director
- Offering amount
- $20.4M
- Amount sold
- $12.4M
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through Pear Therapeutics went on to found or lead other companies.
Kirthiga ReddyBoard Of Directors, Nominating and Corporate Governance CommitteeFounded Optimizegeo +1Michael LangerAssociate Director and Head of Search, Evaluation and In-licensing, Corporate DevelopmentFounded T.Rx CapitalDr Arjun GoyalInterim Vice President, Corporate DevelopmentFounded Affini-T TherapeuticsWilliam GreeneCo-FounderFounded Fountain Therapeutics
In the news
Frequently asked questions
- What does Pear Therapeutics do?
- Pioneering the development of prescription digital therapeutics.
- Who founded Pear Therapeutics?
- Pear Therapeutics was founded by Corey McCann in 2013.
- Who are Pear Therapeutics's investors?
- Pear Therapeutics's investors include JAZZ Venture Partners, 5AM Ventures, Arboretum Ventures, General Catalyst, SoftBank Group.
- How much funding has Pear Therapeutics raised?
- Pear Therapeutics has disclosed $254.8M raised across 4 rounds.
- Where is Pear Therapeutics headquartered?
- Pear Therapeutics is headquartered in Boston, US.